The Risk for Guillain-Barré Syndrome Following J&J COVID-19 Vaccination
Researchers sought to assess the incidence of Guillain-Barré syndrome following vaccination for Ad.26.COV2.S (Janssen) and mRNA vaccines.
Researchers sought to assess the incidence of Guillain-Barré syndrome following vaccination for Ad.26.COV2.S (Janssen) and mRNA vaccines.
A history of autoimmune diseases or malignancy may predispose some patients to developing GBS.